Concept And Connotation Of The Geroprotective And Anti-Aging Effects Of Metformin: From AMPK Activation To SASP Suppression
Scientists are increasingly interested in a common diabetes medication for its potential to slow down the aging process. This drug appears to work by influencing fundamental cellular mechanisms that contribute to aging. One of its main actions is to activate a crucial enzyme known as AMP-activated protein kinase (AMPK). Think of AMPK as your cell’s energy manager; when activated, it helps improve metabolism and overall cellular health. Additionally, the medication helps to suppress something called the Senescence-Associated Secretory Phenotype, or SASP. As cells age, they can enter a state called senescence and release a cocktail of inflammatory molecules (SASP) that can harm neighboring healthy cells and contribute to age-related diseases. By reducing this inflammatory output, the drug helps to mitigate chronic inflammation associated with aging. These combined effects, along with its influence on other pathways related to cellular stress and repair, suggest that this medication could offer a way to protect against the various aspects of aging and age-related conditions.
Source: link to paper